002864

----

Panlong Pharmaceutical obtained the drug registration certificate for Glucosamine Sulfate Capsules

Zhitong

Mar 3 at 04:21 AM

I'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, Panlong Pharmaceutical announced that the company has received the "Drug Registration Certificate" for glucosamine sulfate capsules issued by the National Medical Products Administration. Glucosamine sulfate capsules are suitable for primary and secondary osteoarthritis

According to the Zhitong Finance APP, Panlong Pharmaceutical (002864.SZ) announced that the company has received the "Drug Registration Certificate" issued by the National Medical Products Administration for Glucosamine Sulfate Capsules. Glucosamine Sulfate Capsules are suitable for primary and secondary osteoarthritis

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.